Evotec
Boris Wicht has a strong background in IT service delivery and operations. Boris started their career at Hermes Europe GmbH in 2000, where they worked as Leiter Systems Management for a decade. In 2010, they joined Hermes NexTec GmbH as Head of IT Management, responsible for setting up IT in a start-up and defining IT strategy and processes. In 2012, they moved to FIEGE as Global Head of IT Operations, overseeing IT operations on a global scale. Currently, Boris holds the position of Senior Vice President and global Head of IT Service Delivery at Evotec.
Boris Wicht has studied Elektrotechnik, Eletronik und Kommunikationstechnik at Fachhochschule Darmstadt. Boris also pursued Information Technology at the University of Hamburg.
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.